
A new study has revealed that a NMDA receptor antagonist called 93-31 can reduce the volume of damaged brain tissue by more than half in a mouse model of ischemic stroke. Researchers also found that administering 93-31 to the mice does not seem to lead to the psychoactive side effects seen with other NMDA receptor antagonists. In the 1990s, researchers identified a class of drugs, NMDA receptor antagonists, that showed promise in the area of stroke. NMDA receptors ...

http://ift.tt/1B105We
http://ift.tt/1BWgEAm
No comments:
Post a Comment